Design, synthesis and biological activity evaluation of a new class of 2,4-thiazolidinedione compounds as insulin enhancers
Diabetes mellitus (DM) is a global disease with a high incidence of type 2 diabetes. Current studies have shown that insulin enhancers play an important role in the treatment of type 2 diabetes and have great importance in the improvement of type 2 diabetes. In this research, Rosiglitazone was taken...
Saved in:
Main Authors: | Zou Huiying (Author), Chen Guangying (Author), Zhou Shiyang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design, synthesis of new 2,4-thiazolidinediones: In-silico, in-vivo anti-diabetic and anti-inflammatory evaluation
by: Shankar Gharge, et al.
Published: (2024) -
The inhibition of adenylate kinase by 2,4-thiazolidinedione evaluated by protein-ligand docking
by: Mihaela Ileana Ionescu
Published: (2017) -
Antimicrobial screening of new 5-(chromene-3-yl) methylene-2,4-thiazolidinediones
by: Cristina Nastasă, et al.
Published: (2015) -
Antimicrobial screening of new 5-(chromene-3-yl)methylene-2,4-thiazolidinediones
by: Cristina Nastas?, et al.
Published: (2015) -
Synthesis and biological evaluation of thiazolidinedione derivatives with high ligand efficiency to P. aeruginosa PhzS
by: Thamires Quadros Froes, et al.
Published: (2021)